Yue Wei

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang, Carlos E. Bueso‐Ramos, Courtney DiNardo et al. · Leukemia · 2013 · 670 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Hematology +5

Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia

S-Q Kuang, W. Tong, Hui Yang et al. · Leukemia · 2008 · 160 citations

Chromatin, Epigenetic Change, Genetics +11

Toll-like receptor alterations in myelodysplastic syndrome

Yue Wei, Sophie Dimicoli, Carlos E. Bueso‐Ramos et al. · Leukemia · 2013 · 158 citations · Full text

Toll-like Receptors, Toll-like Receptor Alterations, Autoimmune Disease +6

Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact

Wei-Gang Tong, William G. Wierda, E. Lin et al. · Epigenetics · 2010 · 117 citations · Full text

Histone Modifications, Engineering, Chronic Lymphocytic Leukemia +22

Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome

Simona Colla, Derrick Sek Tong Ong, Yamini Ogoti et al. · Cancer Cell · 2015 · 103 citations · Full text

Myelodysplastic Syndrome, Bone Marrow Failure, Genetics +6